Evidence map›Paper›PMID 17089209›Full record

ArticleMolecular biology reports2006

A novel zinc-finger protein ZNF436 suppresses transcriptional activities of AP-1 and SRE.

Yongqing Li, Xiaoyan Du, Fang Li, Yun Deng, Zhiyuan Yang, Yuequn Wang, Zhonglu Pen, Zequn Wang, Wuzhou Yuan, Chuanbing Zhu and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Yongqing LiThe Center for Heart Development, College of Life Sciences, Hunan Normal University, 410081, Changsha, Hunan, People's Republic of China.
Xiaoyan Du
Fang Li
Yun Deng
Zhiyuan Yang
Yuequn Wang
Zhonglu Pen
Zequn Wang
Wuzhou Yuan
Chuanbing Zhu
Xiushan Wu
Hunan Normal University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitogen-activated protein kinases (MAPKs) are evolutionary conserved enzymes in cell signal transduction connecting cell-surface receptors to critical regulatory targets within cells and control cell survival, adaptation, and proliferation. Previous studies revealed that zinc finger proteins are involved in the regulation of the MAPK signaling pathways. Here we report the identification and characterization of a novel human zinc finger protein, ZNF436. The cDNA of ZNF436 is 3.8 kb, encoding 470 amino acids in the nucleus. The protein is highly conserved in evolution across different vertebrate species from rat to human. RT-PCR indicates that ZNF436 is expressed in all the human fetal tissues examined, with a high level in brain and heart. Overexpression of pCMV-tag2A-ZNF436 in the COS-7 cells represses the transcriptional activities of SRE and AP-1. These results suggest that ZNF436 is a member of the zinc finger transcription factor family and may act as a negative regulator in gene transcription mediated by the MAPK signaling pathways.

Indexed as

Down-RegulationZinc FingersAmino Acid SequenceAnimalsBase SequenceChlorocebus aethiopsCloning, MolecularCOS CellsDNA-Binding ProteinsEvolution, MolecularGreen Fluorescent ProteinsHeartHumansMolecular Sequence DataMyocardiumPhylogenyDNA-Binding ProteinsGreen Fluorescent ProteinsSRE protein, humanTranscription Factor AP-1Transcription FactorsZNF436 protein, human

Identifiers

PMID17089209
OpenAlexW2039684202

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.